We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£520.00
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
Price data last checked 80 day(s) ago - refreshing...
Price History & Forecast
Last 11 days • 11 data points (No recent data available)
Price Distribution
Price distribution over 11 days • 1 price levels
Price Analysis
Most common price: £520 (11 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 11 days
Product Specifications
- Format
- paperback
- ASIN
- B0BLP1ZZRQ
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 10 November 2022
Similar Products You Might Like
97% match
The 2023-2028 Outlook for Osteoporosis Treatments in the United States
£520.00
26 Jan 2026
97% match
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
£520.00
05 Feb 2026
97% match
The 2023-2028 Outlook for Obesity Treatments in the United States
£520.00
23 Mar 2026
97% match
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
£520.00
31 Jan 2026
97% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
£520.00
14 Jan 2026
97% match
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
£520.00
03 Feb 2026
97% match
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
£520.00
13 Jan 2026
97% match
The 2023-2028 Outlook for Macular Degeneration Treatments in the United States
£520.00
30 Jan 2026
97% match
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
£520.00
15 Jan 2026
97% match
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
£520.00
05 Feb 2026
97% match
The 2023-2028 Outlook for Vitamin Deficiency Treatments in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
£520.00
07 Feb 2026
97% match
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States
£520.00
07 Feb 2026
97% match
The 2023-2028 Outlook for Cellulite Treatments in the United States
£520.00
26 Jan 2026
97% match
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
£520.00
14 Jan 2026
97% match
The 2023-2028 Outlook for Diabetes Treatments in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Statins in the United States
£520.00
26 Jan 2026
97% match
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
£520.00
05 Feb 2026
97% match
The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in the United States
£520.00
30 Jan 2026
97% match
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
£520.00
26 Feb 2026
97% match
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States
£520.00
24 Jan 2026
97% match
The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States
£520.00
30 Jan 2026
97% match
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States
£520.00
21 Apr 2026